If I Could Use Gene Therapy to Cure My Manic-Depression, I Don’t Know Whether I Would
By Tana Wojczuk,
Slate
| 09. 21. 2021
In the final chapter of her 1995 memoir of manic-depression, An Unquiet Mind, Kay Redfield Jamison posed a question that has stayed on my mind ever since: “I have often asked myself whether, given the choice, I would choose to have manic-depressive illness.” The question haunts me because I can’t answer it, either.
When Jamison first posed her question (if there were a cure for my mental illness, would I take it?), it seemed like pure speculation. But the question is no longer so hypothetical.
In June, the journal Nature Reviews Neurology published the results of a wide-ranging study of the genetic roots of manic depression. The study included 40,000 cases and identified a startling 64 genes associated with the disease. (In a clinical setting, the disease is usually referred to as “bipolar disorder,” though I’ve always preferred the more descriptive “manic-depression.”) Studies like this one are part of a burgeoning discipline known as molecular psychiatry, a field that studies the “biological mechanisms underlying psychiatric disorders.” Molecular biologists are also making progress in studies of major (unipolar)...
Related Articles
Flag of South Africa; design by Frederick Brownell,
image by WikimediaCommons users.
Public domain, via Wikimedia Commons
What is the legal status of heritable human genome editing (HHGE)? In 2020, a comprehensive policy analysis by Baylis, Darnovsky, Hasson, and Krahn documented that more than 70 countries and an international treaty prohibit it, and that no country explicitly permits it. Policies in some countries were non-existent, ambiguous, or subject to possible amendment, but the general rule remained, even after one...
By Bernice Lottering, Gene Online | 11.08.2024
South Africa’s updated health-research ethics guidelines, which now include heritable human genome editing, have sparked concern among scientists. The revisions, made in May but only recently gaining attention, outline protocols for modifying genetic material in sperm, eggs, or embryos—changes...
By Jim Thomas, Scan the Horizon | 11.19.2024
It’s the wee hours of 2nd November 2024 in Cali, Colombia. In a large UN negotiating hall Colombian Environment Minister Susana Muhamed has slammed down the gavel on a decision that should send a jolt through the AI policy world. ...
By Ned Pagliarulo, BioPharmaDive | 11.05.2024
A medicine built around a more precise form of CRISPR gene editing appeared to work as designed in its first clinical trial test, developer Beam Therapeutics said Tuesday. But the death of a trial participant could renew concerns about an older...